IL6 and rheumatoid arthritis: Pre-treatment of both human RA-FLS and THP-1 cells with KMU-11342 resulted in the inhibition of LPS-induced up-regulation of pro-inflammatory cytokines such as IL-1β, TNF-α, and IL-6 (Fig. 3G–N).